← Nazad


Kissling E



Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies. Eurosurveillance 2018;23. doi:10.2807/1560-7917.ES.2018.23.9.18-00086.

Autori: Rondy M, Kissling E, Emborg H-D, Gherasim A, Pebody R, Trebbien R
Godina: 2018

2015/16 I-MOVE/I-MOVE+ multicentre case control study in Europe: moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage mismatched influenza B among children. Influenza Other Respir Viruses. 2017 Nov 10. doi: 10.1111/irv.12520. [Epub ahead of print]

Autori: Kissling E, Valenciano M, Pozo F, Vilcu AM, Reuss A, Rizzo C, Larrauri A, Horváth JK, Brytting M, Domegan L, Korczyńska M, Meijer A, Machado A, Ivanciuc A, Višekruna Vučina V, van der Werf S, Schweiger B, Bella A, Gherasim A, Ferenczi A, Zakikhany K, O Donnell J, Paradowska-Stankiewicz I, Dijkstra F, Guiomar R, Lazar M, Kurečić Filipović S, Johansen K, Moren A, I-MOVE/I-MOVE+ study team
Godina: 2017

Influenza vaccine effectiveness estimates in Croatia in 2010–2011: a season with predominant circulation of A(H1N1)pdm09 influenza virus. Epidemiol Infect. 2015;143(12):2596-603 – u prilogu

Autori: Kurečić Filipović S, Gjenero-Margan I, Kissling E, Kaic B, Cvitkovic A
Godina: 2015